RNF138 contributes to cisplatin resistance in nasopharyngeal carcinoma cells
Abstract Resistance to chemotherapy is a significant concern in the treatment of nasopharyngeal carcinoma (NPC), and occurs due to various mechanisms. This study is aimed to evaluate the effects of RING finger protein 138 (RNF138) in the development of cisplatin resistance to NPC. After gene overexp...
Saved in:
| Main Authors: | Hangyu Xu, Qing Yin, Linna Fan, Yating Zhao, Biying Song, Qifan Xu, Jie Zhu, Meifen Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85716-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RNF144A and RNF144B: Important molecules for health
by: Jiang Wang, et al.
Published: (2025-08-01) -
The gold complex auranofin sensitizes platinum resistant epithelial ovarian cancer cells to cisplatin
by: Farah H. Abdalbari, et al.
Published: (2025-06-01) -
The E3 ubiquitin ligase RNF6 facilitates the progression of cervical cancer by inhibiting the Hippo/Yap pathway
by: Yawen Liu, et al.
Published: (2024-11-01) -
RNF20/RNF40 supports the aggressive behavior in cervical cancer by regulating a peroxisome-based anti-ferroptotic mechanism
by: Shaishavi Jansari, et al.
Published: (2025-07-01) -
Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial
by: Qihua Zou, et al.
Published: (2025-05-01)